Nuo Therapeutics, Inc. (AURX) Stock buybacks
Nuo Therapeutics, Inc. (AURX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$471FY2018
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | $471 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AURX financial trends
AURX RevenueAURX Net incomeAURX Net marginAURX Gross profitAURX Gross marginAURX Operating incomeAURX Operating marginAURX Operating cash flowAURX Free cash flowAURX Capital expendituresAURX Return on equityAURX Dividends paidAURX Total assetsAURX Total liabilitiesAURX Shareholders’ equityAURX overview →